ClinicalMetric / Countries / Japan / recurrent head and neck squamous cell carcinoma
← 🇯🇵 Japan Trials
🇯🇵 Japan Country × Condition

recurrent head and neck squamous cell carcinoma Clinical Trials in Japan

Active clinical trials for recurrent head and neck squamous cell carcinoma with research sites in Japan. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 1 // Recruiting: 1 Phases: Phase 3 // Updated: Daily
Total Trials
1
Recruiting Now
1
Country
🇯🇵 Japan

Active Trials in Japan (1)

NCT06699212 Phase 3
Recruiting

A Study of ASP-1929 Photoimmunotherapy in Combination With Pembrolizumab in First-line Treatment of Locoregional Recurrent Squamous Cell Carcinoma of the Head and Neck With No Distant Metastases

Enrollment
412 pts
Country
🇯🇵 Japan
Rakuten Medical, Inc.
View Trial →

Frequently Asked Questions

How many recurrent head and neck squamous cell carcinoma clinical trials are active in Japan?
There are currently 1 active clinical trials for recurrent head and neck squamous cell carcinoma with sites in Japan, of which 1 are actively recruiting patients.
How can I join a recurrent head and neck squamous cell carcinoma clinical trial in Japan?
To join a recurrent head and neck squamous cell carcinoma clinical trial in Japan, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Japan directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are recurrent head and neck squamous cell carcinoma trials in Japan?
Active recurrent head and neck squamous cell carcinoma trials in Japan span Phase 3. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Japan Trials → Global recurrent head and neck squamous cell carcinoma Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology